Variant report

Variant	nsv461202
Chromosome Location	chr4:7311399-7333152
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF3	chr4:7325347-7326029	A549	lung:	n/a	n/a
2	ATF3	chr4:7325569-7325906	A549	lung:	n/a	n/a
3	BHLHE40	chr4:7332888-7333034	K562	blood:	n/a	chr4:7332974-7332983 chr4:7332968-7332989 chr4:7332975-7332984 chr4:7332974-7332983 chr4:7332972-7332985
4	BHLHE40	chr4:7326359-7326668	GM12878	blood:	n/a	n/a
5	CEBPB	chr4:7314937-7315345	MCF-7	breast:	n/a	chr4:7315161-7315170 chr4:7315161-7315170 chr4:7315161-7315170 chr4:7315160-7315171 chr4:7315161-7315170
6	CEBPB	chr4:7324731-7324857	HepG2	liver:	n/a	n/a
7	CEBPB	chr4:7314905-7315396	A549	lung:	n/a	chr4:7315161-7315170 chr4:7315161-7315170 chr4:7315161-7315170 chr4:7315160-7315171 chr4:7315161-7315170
8	CEBPB	chr4:7315029-7315275	ECC-1	luminal epithelium:	n/a	chr4:7315161-7315170 chr4:7315161-7315170 chr4:7315161-7315170 chr4:7315160-7315171 chr4:7315161-7315170
9	CEBPB	chr4:7315082-7315202	HepG2	liver:	n/a	chr4:7315161-7315170 chr4:7315161-7315170 chr4:7315161-7315170 chr4:7315160-7315171 chr4:7315161-7315170
10	CEBPB	chr4:7314974-7315334	A549	lung:	n/a	chr4:7315161-7315170 chr4:7315161-7315170 chr4:7315161-7315170 chr4:7315160-7315171 chr4:7315161-7315170
11	CEBPB	chr4:7314956-7315381	ECC-1	luminal epithelium:	n/a	chr4:7315161-7315170 chr4:7315161-7315170 chr4:7315161-7315170 chr4:7315160-7315171 chr4:7315161-7315170
12	CEBPB	chr4:7314975-7315352	K562	blood:	n/a	chr4:7315161-7315170 chr4:7315161-7315170 chr4:7315161-7315170 chr4:7315160-7315171 chr4:7315161-7315170
13	CEBPB	chr4:7314975-7315351	IMR90	lung:	n/a	chr4:7315161-7315170 chr4:7315161-7315170 chr4:7315161-7315170 chr4:7315160-7315171 chr4:7315161-7315170
14	CEBPB	chr4:7314977-7315363	H1-hESC	embryonic stem cell:	n/a	chr4:7315161-7315170 chr4:7315161-7315170 chr4:7315161-7315170 chr4:7315160-7315171 chr4:7315161-7315170
15	CEBPB	chr4:7314977-7315349	HepG2	liver:	n/a	chr4:7315161-7315170 chr4:7315161-7315170 chr4:7315161-7315170 chr4:7315160-7315171 chr4:7315161-7315170
16	CEBPB	chr4:7315008-7315270	K562	blood:	n/a	chr4:7315161-7315170 chr4:7315161-7315170 chr4:7315161-7315170 chr4:7315160-7315171 chr4:7315161-7315170
17	CEBPB	chr4:7314983-7315346	A549	lung:	n/a	chr4:7315161-7315170 chr4:7315161-7315170 chr4:7315161-7315170 chr4:7315160-7315171 chr4:7315161-7315170
18	CEBPB	chr4:7314946-7315363	MCF-7	breast:	n/a	chr4:7315161-7315170 chr4:7315161-7315170 chr4:7315161-7315170 chr4:7315160-7315171 chr4:7315161-7315170
19	CEBPB	chr4:7324654-7324913	IMR90	lung:	n/a	chr4:7324854-7324865
20	CEBPB	chr4:7315017-7315331	Hela-S3	cervix:	n/a	chr4:7315161-7315170 chr4:7315161-7315170 chr4:7315161-7315170 chr4:7315160-7315171 chr4:7315161-7315170
21	CTCF	chr4:7325760-7325910	HPAF	blood vessel:	n/a	n/a
22	CTCF	chr4:7324020-7324170	GM12865	blood:	n/a	n/a
23	CTCF	chr4:7325680-7325830	HVMF	connective:	n/a	n/a
24	CTCF	chr4:7325720-7325870	Caco-2	colon:	n/a	n/a
25	CTCF	chr4:7330660-7330810	AG04449	skin:	n/a	n/a
26	CTCF	chr4:7330620-7330770	HCT-116	colon:	n/a	n/a
27	CTCF	chr4:7325760-7325910	GM12873	blood:	n/a	n/a
28	CTCF	chr4:7325807-7325855	MCF-7	breast:	n/a	n/a
29	CTCF	chr4:7330720-7330870	HCPEpiC	choroid plexus:	n/a	n/a
30	CTCF	chr4:7323980-7324130	WERI-Rb-1	eye:	n/a	n/a
31	CTCF	chr4:7325780-7325930	GM12864	blood:	n/a	n/a
32	CTCF	chr4:7330720-7330870	Hela-S3	cervix:	n/a	n/a
33	CTCF	chr4:7330680-7330830	RPTEC	kidney:	n/a	n/a
34	CTCF	chr4:7330500-7330650	AG10803	skin:	n/a	n/a
35	CTCF	chr4:7325772-7325894	MCF-7	breast:	n/a	n/a
36	CTCF	chr4:7325780-7325930	GM12867	blood:	n/a	n/a
37	CTCF	chr4:7325796-7325827	IMR90	lung:	n/a	n/a
38	CTCF	chr4:7325720-7325870	HCPEpiC	choroid plexus:	n/a	n/a
39	CTCF	chr4:7325760-7325910	HepG2	liver:	n/a	n/a
40	CTCF	chr4:7325660-7325971	K562	blood:	n/a	n/a
41	CTCF	chr4:7325712-7325945	A549	lung:	n/a	n/a
42	CTCF	chr4:7325875-7325877	H1-hESC	embryonic stem cell:	n/a	n/a
43	CTCF	chr4:7332040-7332190	WERI-Rb-1	eye:	n/a	n/a
44	CTCF	chr4:7325740-7325890	AG04449	skin:	n/a	n/a
45	CTCF	chr4:7330500-7330650	AG09319	gingival:	n/a	n/a
46	CTCF	chr4:7325780-7325930	SK-N-SH_RA	brain:	n/a	n/a
47	CTCF	chr4:7330680-7330830	AG10803	skin:	n/a	n/a
48	CTCF	chr4:7332400-7332550	WERI-Rb-1	eye:	n/a	n/a
49	CTCF	chr4:7325720-7325870	GM12864	blood:	n/a	n/a
50	CTCF	chr4:7325780-7325930	GM12869	blood:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:7326576-7326626	GM12891	blood:	n/a
2	chr4:7330616-7330666	A549	lung:	n/a
3	chr4:7326576-7326626	AG10803	skin:	n/a
4	chr4:7330616-7330666	AG09319	gingival:	n/a
5	chr4:7326576-7326626	HIPEpiC	eye:	n/a
6	chr4:7326576-7326626	HRCEpiC	kidney:	n/a
7	chr4:7330616-7330666	AG04450	lung:	fetal
8	chr4:7330616-7330666	HCPEpiC	choroid plexus:	n/a
9	chr4:7330616-7330666	GM19239	blood:	n/a
10	chr4:7330616-7330666	NT2-D1	testis:	n/a
11	chr4:7330616-7330666	HNPCEpiC	eye:	n/a
12	chr4:7326576-7326626	PFSK-1	brain:	n/a
13	chr4:7326576-7326626	HNPCEpiC	eye:	n/a
14	chr4:7330616-7330666	NHBE	bronchial:	n/a
15	chr4:7326576-7326626	GM12892	blood:	n/a
16	chr4:7330616-7330666	HAEpiC	amniotic membrane:	n/a
17	chr4:7326576-7326626	K562	blood:	n/a
18	chr4:7326576-7326626	GM12878	blood:	n/a
19	chr4:7330616-7330666	SAEC	small airway:	n/a
20	chr4:7326576-7326626	Hepatocyte	liver:	n/a
21	chr4:7330616-7330666	AG04449	skin:	fetal
22	chr4:7326576-7326626	Hela-S3	cervix:	n/a
23	chr4:7330616-7330666	AoSMC	blood vessel:	n/a
24	chr4:7326576-7326626	ECC-1	luminal epithelium:	n/a
25	chr4:7330616-7330666	Hela-S3	cervix:	n/a
26	chr4:7326576-7326626	HPAEpiC	pulmonary alveolar:	n/a
27	chr4:7326576-7326626	MCF10A-Er-Src	breast:	n/a
28	chr4:7326576-7326626	HCPEpiC	choroid plexus:	n/a
29	chr4:7330616-7330666	T-47D	breast:	n/a
30	chr4:7330616-7330666	GM12878	blood:	n/a
31	chr4:7326576-7326626	AG09319	gingival:	n/a
32	chr4:7326576-7326626	NHDF-neo	bronchial:	n/a
33	chr4:7326576-7326626	SK-N-MC	brain:	n/a
34	chr4:7330616-7330666	AG09309	skin:	n/a
35	chr4:7326576-7326626	SK-N-SH_RA	brain:	n/a
36	chr4:7326576-7326626	ProgFib	skin:	n/a
37	chr4:7330616-7330666	HCF	heart:	n/a
38	chr4:7326576-7326626	LNCaP	prostate:	n/a
39	chr4:7330616-7330666	PrEC	prostate:	n/a
40	chr4:7326576-7326626	HCM	heart:	n/a
41	chr4:7330616-7330666	AG10803	skin:	n/a
42	chr4:7330616-7330666	SKMC	muscle:	n/a
43	chr4:7326576-7326626	RPTEC	kidney:	n/a
44	chr4:7330616-7330666	RPTEC	kidney:	n/a
45	chr4:7326576-7326626	AoSMC	blood vessel:	n/a
46	chr4:7330616-7330666	PFSK-1	brain:	n/a
47	chr4:7326576-7326626	ovcar-3	ovarian:	n/a
48	chr4:7326576-7326626	A549	lung:	n/a
49	chr4:7326576-7326626	PANC-1	pancreas:	n/a
50	chr4:7330616-7330666	NHDF-neo	bronchial:	n/a

No.	Distal block	Cell Line	Cell type
1	chr4:7328869..7330375-chr4:7332248..7333752,2	MCF-7	breast:
2	chr4:7320638..7322307-chr4:7344162..7346358,2	K562	blood:
3	chr4:7308048..7310472-chr4:7320955..7323841,2	MCF-7	breast:
4	chr4:7328869..7330375-chr4:7332248..7333752,2	MCF-7	breast:
5	chr4:7331028..7333099-chr4:7336513..7338486,2	K562	blood:

miRNA name	Chromosome Location	mirBase accession
hsa-miR-4798-3p	chr4:7312223-7312244	MIMAT0019975
hsa-miR-4798-5p	chr4:7312186-7312207	MIMAT0019974

Variant related genes	Relation type
MIR4798	TF binding region
MIR4798	CpG island

Extended variants
information (count: 1169 )
Associated
traits (count: 55 )

Variant overlapped rSNPs/rCNVs (count:1169 , 50 per page) page: 1 2 3 4 5 6 7 ... 24

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs3846426	chr4:7311399-7311400	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs558941979	chr4:7311414-7311415	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs370783166	chr4:7311427-7311428	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs181576400	chr4:7311449-7311450	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs75847122	chr4:7311458-7311459	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs201080338	chr4:7311467-7311468	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs73208451	chr4:7311469-7311470	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs112971440	chr4:7311474-7311475	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs535542868	chr4:7311478-7311479	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs73796623	chr4:7311494-7311495	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs575776412	chr4:7311531-7311532	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs114384875	chr4:7311532-7311533	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs113391185	chr4:7311535-7311536	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs4689695	chr4:7311539-7311540	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
15	rs540626501	chr4:7311544-7311545	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs559593146	chr4:7311545-7311546	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs529678145	chr4:7311591-7311592	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs4689696	chr4:7311595-7311596	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs563396329	chr4:7311603-7311604	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs191084442	chr4:7311610-7311611	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs552360514	chr4:7311623-7311624	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs570763546	chr4:7311628-7311629	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs534889588	chr4:7311699-7311700	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs547030671	chr4:7311754-7311755	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs535558794	chr4:7311798-7311799	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs145950895	chr4:7311825-7311826	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs567447319	chr4:7311828-7311829	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs184023258	chr4:7311847-7311848	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs557220902	chr4:7311868-7311869	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs563144619	chr4:7311869-7311870	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs539653035	chr4:7311891-7311892	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs549831373	chr4:7311899-7311900	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs557882082	chr4:7311911-7311912	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs573220978	chr4:7311919-7311920	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs4689697	chr4:7311922-7311923	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs562387051	chr4:7312017-7312018	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs574398816	chr4:7312043-7312044	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs143485984	chr4:7312047-7312048	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs3930439	chr4:7312054-7312055	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs563248508	chr4:7312067-7312068	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs530581473	chr4:7312074-7312075	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs552424157	chr4:7312125-7312126	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs554216307	chr4:7312127-7312128	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs528278442	chr4:7312133-7312134	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs370283885	chr4:7312135-7312136	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs11942816	chr4:7312145-7312146	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
47	rs568339519	chr4:7312204-7312205	Weak transcription Active TSS Enhancers Bivalent Enhancer	miRNA	n/a	Overlapped CNVs	n/a
48	rs114771990	chr4:7312222-7312223	Weak transcription Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs550909324	chr4:7312229-7312230	Weak transcription Active TSS Enhancers Bivalent Enhancer	miRNA	n/a	Overlapped CNVs	n/a
50	rs569252945	chr4:7312261-7312262	Weak transcription Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:55)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Melanoma	20688739	CNVD
Colorectal cancer	16272173	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17603634	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Colorectal cancer	19359472	CNVD
Neuroblastoma	17533364	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Cancer	21637783	CNVD
Melanoma	21693616	CNVD
Squamous cell cancer	21044232	CNVD
Colorectal cancer	20709793	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Non-small cell lung cancer	21044232	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Cervical cancer	21062161	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Neuroblastoma	18923191	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21785460	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Breast cancer	21509527	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Schizophrenia	22241247	CNVD
Autosomal-dominant microtia	18179897	CNVD
Glioma	17123091	CNVD
Colorectal cancer	20459617	CNVD
Breast cancer	17133270	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Melanoma	20877625	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:371 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:7307200-7316200	Enhancers	Brain Inferior Temporal Lobe	brain
2	chr4:7307600-7311800	Enhancers	Brain Substantia Nigra	brain
3	chr4:7307600-7312000	Bivalent Enhancer	Fetal Muscle Leg	muscle
4	chr4:7307600-7312400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
5	chr4:7308400-7311400	Enhancers	Right Ventricle	heart
6	chr4:7308400-7313000	Enhancers	Breast Myoepithelial Primary Cells	Breast
7	chr4:7308600-7311600	Enhancers	Fetal Heart	heart
8	chr4:7308600-7313000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
9	chr4:7308600-7313200	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
10	chr4:7309600-7311800	Weak transcription	Fetal Brain Female	brain
11	chr4:7309800-7312400	Weak transcription	HSMMtube	muscle
12	chr4:7309800-7314000	Weak transcription	Brain Hippocampus Middle	brain
13	chr4:7309800-7314600	Weak transcription	Fetal Lung	lung
14	chr4:7310400-7313400	Enhancers	Brain Cingulate Gyrus	brain
15	chr4:7310600-7311600	Enhancers	Left Ventricle	heart
16	chr4:7310600-7313400	Enhancers	Brain Angular Gyrus	brain
17	chr4:7310800-7311800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
18	chr4:7310800-7311800	Enhancers	Fetal Brain Male	brain
19	chr4:7311000-7311800	Enhancers	Stomach Smooth Muscle	stomach
20	chr4:7311000-7312000	Enhancers	Skeletal Muscle Female	skeletal muscle
21	chr4:7311000-7313000	Enhancers	Brain Anterior Caudate	brain
22	chr4:7311200-7311400	Enhancers	ES-I3 Cell Line	embryonic stem cell
23	chr4:7311200-7311400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
24	chr4:7311200-7311400	Enhancers	Fetal Thymus	thymus
25	chr4:7311200-7311800	Enhancers	H1 Cell Line	embryonic stem cell
26	chr4:7311200-7311800	Enhancers	HUES64 Cell Line	embryonic stem cell
27	chr4:7311200-7312200	Weak transcription	Brain Germinal Matrix	brain
28	chr4:7311400-7311600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
29	chr4:7311400-7311800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
30	chr4:7311400-7312600	Enhancers	Fetal Stomach	stomach
31	chr4:7311400-7314400	Weak transcription	Fetal Thymus	thymus
32	chr4:7311400-7315000	Weak transcription	ES-I3 Cell Line	embryonic stem cell
33	chr4:7311400-7315000	Weak transcription	Right Ventricle	heart
34	chr4:7311600-7314200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
35	chr4:7311800-7312000	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
36	chr4:7311800-7312000	Enhancers	Fetal Brain Female	brain
37	chr4:7311800-7312200	Weak transcription	Brain Substantia Nigra	brain
38	chr4:7311800-7312400	Enhancers	Ovary	ovary
39	chr4:7311800-7314400	Weak transcription	Stomach Smooth Muscle	stomach
40	chr4:7311800-7314800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
41	chr4:7311800-7315000	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
42	chr4:7311800-7326400	Weak transcription	Fetal Brain Male	brain
43	chr4:7312000-7312200	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
44	chr4:7312000-7312600	Weak transcription	Fetal Brain Female	brain
45	chr4:7312000-7313000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
46	chr4:7312000-7313000	Weak transcription	Skeletal Muscle Female	skeletal muscle
47	chr4:7312000-7313400	Enhancers	Fetal Muscle Leg	muscle
48	chr4:7312200-7312400	Enhancers	Brain Germinal Matrix	brain
49	chr4:7312200-7312600	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
50	chr4:7312200-7313400	Enhancers	Brain Substantia Nigra	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links